Trevi Therapeutics (TRVI) News Today $8.48 -0.07 (-0.85%) As of 10:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRVI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period How Investors May Respond To Trevi Therapeutics (TRVI) Highlighting RIVER Trial Data at ERS 2025September 20 at 1:59 PM | finance.yahoo.comTrevi Therapeutics Announces Two Posters from the Phase 2a RIVER Trial Data Will be Featured at the European Respiratory Society (ERS) Congress 2025September 18, 2025 | prnewswire.comTrevi Therapeutics (NASDAQ:TRVI) Shares Down 4.6% - Should You Sell?September 14, 2025 | marketbeat.comTrevi Therapeutics, Inc. $TRVI Shares Sold by Woodline Partners LPSeptember 14, 2025 | marketbeat.comTrevi Therapeutics (NASDAQ:TRVI) Sees Strong Trading Volume - Still a Buy?September 13, 2025 | marketbeat.comFred Alger Management LLC Invests $482,000 in Trevi Therapeutics, Inc. $TRVISeptember 13, 2025 | marketbeat.comSiren L.L.C. Sells 42,267 Shares of Trevi Therapeutics, Inc. $TRVISeptember 13, 2025 | marketbeat.comTrevi Therapeutics (NASDAQ:TRVI) Hits New 12-Month High - Should You Buy?September 12, 2025 | marketbeat.comBrokerages Set Trevi Therapeutics, Inc. (NASDAQ:TRVI) Target Price at $21.75September 12, 2025 | americanbankingnews.comHaduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan StanleySeptember 11, 2025 | msn.comTrevi Therapeutics, Inc. $TRVI Stock Position Raised by Acorn Capital Advisors LLCSeptember 11, 2025 | marketbeat.comExome Asset Management LLC Takes $1.03 Million Position in Trevi Therapeutics, Inc. $TRVISeptember 11, 2025 | marketbeat.comOctagon Capital Advisors LP Makes New $20.90 Million Investment in Trevi Therapeutics, Inc. $TRVISeptember 11, 2025 | marketbeat.comTrevi Therapeutics, Inc. (NASDAQ:TRVI) Given Consensus Rating of "Buy" by AnalystsSeptember 11, 2025 | marketbeat.comTrevi Therapeutics (NASDAQ:TRVI) Trading 8.9% Higher - Here's WhySeptember 10, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Reduces Holdings in Trevi Therapeutics, Inc. $TRVISeptember 10, 2025 | marketbeat.comTrevi Therapeutics, Inc. (TRVI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 9, 2025 | seekingalpha.comPolar Asset Management Partners Inc. Acquires Shares of 64,050 Trevi Therapeutics, Inc. $TRVISeptember 9, 2025 | marketbeat.comTrevi Therapeutics, Inc. $TRVI Stock Holdings Boosted by Cubist Systematic Strategies LLCSeptember 9, 2025 | marketbeat.comTrevi Therapeutics, Inc. $TRVI Holdings Lifted by Raymond James Financial Inc.September 9, 2025 | marketbeat.comAlly Bridge Group NY LLC Sells 95,270 Shares of Trevi Therapeutics, Inc. $TRVISeptember 5, 2025 | marketbeat.comTrevi Therapeutics, Inc. $TRVI Stock Position Lifted by Panagora Asset Management Inc.September 5, 2025 | marketbeat.comTrevi Therapeutics, Inc. $TRVI Shares Bought by MPM Bioimpact LLCSeptember 4, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Sells 405,365 Shares of Trevi Therapeutics, Inc. $TRVISeptember 4, 2025 | marketbeat.comBraidwell LP Takes Position in Trevi Therapeutics, Inc. $TRVISeptember 3, 2025 | marketbeat.comWellington Management Group LLP Makes New $802,000 Investment in Trevi Therapeutics, Inc. $TRVISeptember 3, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Buys 34,455 Shares of Trevi Therapeutics, Inc. $TRVISeptember 3, 2025 | marketbeat.comArmistice Capital LLC Purchases New Stake in Trevi Therapeutics, Inc. $TRVISeptember 2, 2025 | marketbeat.comTrevi Therapeutics, Inc. $TRVI Shares Bought by Jump Financial LLCSeptember 1, 2025 | marketbeat.comNuveen LLC Makes New Investment in Trevi Therapeutics, Inc. $TRVISeptember 1, 2025 | marketbeat.comVanguard Group Inc. Raises Position in Trevi Therapeutics, Inc. $TRVIAugust 31, 2025 | marketbeat.comTrevi Therapeutics (NASDAQ:TRVI) Hits New 52-Week High - Time to Buy?August 30, 2025 | marketbeat.comInvesco Ltd. Acquires 829,364 Shares of Trevi Therapeutics, Inc. $TRVIAugust 30, 2025 | marketbeat.comTrevi spikes as B. Riley reportedly cites deal prospectsAugust 28, 2025 | msn.comAffinity Asset Advisors LLC Takes $7.86 Million Position in Trevi Therapeutics, Inc. $TRVIAugust 28, 2025 | marketbeat.comTrevi Therapeutics to Participate in Upcoming September ConferencesAugust 28, 2025 | prnewswire.comTrevi Therapeutics (NASDAQ:TRVI) Coverage Initiated by Analysts at Morgan StanleyAugust 23, 2025 | marketbeat.comMorgan Stanley Initiates Coverage of Trevi Therapeutics (TRVI) with Overweight RecommendationAugust 22, 2025 | msn.comB. Riley Boosts Earnings Estimates for Trevi TherapeuticsAugust 19, 2025 | marketbeat.comTrevi Therapeutics, Inc. (NASDAQ:TRVI) Shares Sold by XTX Topco LtdAugust 17, 2025 | marketbeat.comTrevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Rating of "Buy" from AnalystsAugust 16, 2025 | marketbeat.comPersistent Asset Partners Ltd Makes New $260,000 Investment in Trevi Therapeutics, Inc. (NASDAQ:TRVI)August 13, 2025 | marketbeat.comInformed Momentum Co LLC Invests $3.47 Million in Trevi Therapeutics, Inc. (NASDAQ:TRVI)August 13, 2025 | marketbeat.comTrevi Therapeutics: Optimism Amid Earnings Call InsightsAugust 13, 2025 | msn.comAnalysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), DENTSPLY SIRONA (XRAY) and Arrowhead Pharmaceuticals (ARWR)August 13, 2025 | theglobeandmail.comHC Wainwright Analysts Increase Earnings Estimates for TRVIAugust 12, 2025 | marketbeat.comTrevi Therapeutics (NASDAQ:TRVI) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPSAugust 11, 2025 | marketbeat.comRaymond James Financial Issues Pessimistic Forecast for Trevi Therapeutics (NASDAQ:TRVI) Stock PriceAugust 10, 2025 | marketbeat.comTrevi Therapeutics (NASDAQ:TRVI) Is In A Good Position To Deliver On Growth PlansAugust 10, 2025 | finance.yahoo.comNeedham & Company LLC Lowers Trevi Therapeutics (NASDAQ:TRVI) Price Target to $22.00August 9, 2025 | marketbeat.com Get Trevi Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRVI Media Mentions By Week TRVI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRVI News Sentiment▼0.000.73▲Average Medical News Sentiment TRVI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRVI Articles This Week▼25▲TRVI Articles Average Week Get the Latest News and Ratings for TRVI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ACAD News ADMA News AAPG News MTSR News MIRM News ZLAB News PTGX News LNTH News AKRO News MLTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRVI) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRVI Stock Alerts